Anatara Lifesciences (ASX:ANR) is pleased to announce that the Australian Pesticides and Veterinary Medicines Authority has registered Detach(R) with the approved label, "To aid in the control of scour and has positive health benefits in weaned piglets from 3 weeks of age and help increase survivability of scouring pre-weaning piglets".
Nanollose Limited (ASX:NC6) reminds shareholders that its 2018 Annual General Meeting will be held at 1:00pm WST on Monday, 29 October 2018 at its registered office.
Nanollose Limited (ASX:NC6) is pleased to announce that it has obtained favourable findings from the Department of Industry, Innovation and Science which will enable the Company to claim tax rebates on certain overseas research and development expenditure up to $1.419 million over the next three years.
The Board of Queensland Bauxite Limited (ASX:QBL) is very pleased to announce a materially strategic transaction, that its soon to be wholly owned subsidiary Medcan Australia, has entered into a Strategic Collaboration and Supply Agreement Signed with an established Canadian Licensed Producer of Medical Cannabis.
Regeneus Ltd (ASX:RGS) provides the Company's quarterly results for the period ended 30 September 2018.
Anatara Lifesciences (ASX:ANR), a company focused on commercialising innovative products for gut health, is pleased to announce the formation of its Product Development Advisory Board. The Advisory Board consists of five key external experts: Dr Rebecca Burgell, Dr Jakob Begun, Prof Barry Campbell, Assoc Prof Simon Keely and Prof Peter Gibson, who will serve as the Chairman.
Queensland Bauxite Ltd (ASX:QBL) provides the Company's Annual Report to shareholders.
